Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols.
Positron emission tomography (PET) in conjunction with C15O2 or H215O can be used to measure myocardial blood flow (MBF) and tissue fraction (TF), i.e. the fraction of the tissue mass in the volume of the region of interest. However, with C15O2 inhalation, the tissue fraction in the septum is overestimated. Bolus injection of H215O together with arterial cannulation gives very precise results but is invasive. The purpose of this study was to develop a method which circumvents these problems. A four-parameter model with parameters for MBF, TF and spill-over fractions from both left and right ventricular cavities was developed. This method was compared with a three-parameter model (no right ventricular cavity spill-over) in both septal and non-septal regions of interest for three different administration protocols: bolus injection of H215O, infusion of H215O and inhalation of C15O2. It was found that MBF can be measured with intravenous administration of H215O without the requirement for arterial cannulation. The four-parameter protocol with bolus injection was stable in clinical studies. The four-parameter model proved essential for the septum, where it gave highly significantly better fits than did the three-parameter model (P<0.00003 in each of 15 subjects). Administration of H215O together with this four-parameter model also circumvented the problem of overestimation of TF in the septum seen with C15O2 inhalation. In addition, the radiation dose of H215O protocols is lower than that of C15O2 inhalation. Using a left atrial input curve instead of a left ventricular cavity input curve gave the same mean MBF and TF.
Hermansen
F
F
PET Methodology and Cardiology Groups, MRC Cyclotron Unit, Imperial College School of Medicine, Hammersmith Hospital, London, UK.
Rosen
S D
SD
Fath-Ordoubadi
F
F
Kooner
J S
JS
Clark
J C
JC
Camici
P G
PG
Lammertsma
A A
AA
D000280:Administration, Inhalation; D000328:Adult; D001810:Blood Volume / Q000187:drug effects; D003326:Coronary Circulation / Q000502:physiology*; D005260:Female; D006801:Humans; D006940:Hyperemia / Q000503:physiopathology; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D008297:Male; D008954:Models, Biological; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging; D010104:Oxygen Radioisotopes; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000008:administration & dosage*; D014867:Water
D010104:Oxygen Radioisotopes; D019275:Radiopharmaceuticals; D014867:Water